Results 81 to 90 of about 22,512 (233)
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi +3 more
wiley +1 more source
Screening of Alpha-Thalassaemia 1 in Beta-Thalassaemia Carriers [PDF]
Thalassaemia is an inherited blood disorder in which there is a reduction or absence in the synthesis of the globin chains of human Hb. Thalassaemia remains a public health problem in Malaysia, with many not knowing they carry the gene for ...
Chong, Yi Min
core +1 more source
Summary Cerebral macrovasculopathy (CV) is a major complication in children with sickle cell anaemia (SCA) and usually requires a long‐term transfusion programme (TP) to prevent stroke. This study aimed to identify factors predicting reversal of CV on TP in a single‐centre newborn cohort. Among 375 patients, 50 presented CV and received TP.
Julie Sommet +16 more
wiley +1 more source
IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies
Maria Xenophontos +5 more
doaj +1 more source
Cognitive impairment and hippocampal neuronal damage in β-thalassaemia mice
β-Thalassaemia is one of the most common genetic diseases worldwide. During the past few decades, life expectancy of patients has increased significantly owing to advance in medical treatments. Cognitive impairment, once has been neglected, has gradually
Nuttanan Pholngam +7 more
doaj +1 more source
Objectives Thalassaemia is a genetic disorder of haemoglobin synthesis characterised by life-long chronic anaemia. Although the endocrine and cardiac complications of thalassaemia are well-studied, hepatic and renal complications are understudied.
Meranthi Fernando +7 more
doaj +1 more source
Inherited haemoglobin disorders, including thalassaemia and sickle-cell disease, are the most common monogenic diseases worldwide. Several clinical forms of α-thalassaemia and Î2-thalassaemia, including the co-inheritance of Î2-thalassaemia with ...
Ali T Taher +5 more
core +1 more source
Summary In patients with sickle cell disease (SCD), parvovirus B19 infection (B19V) leads to acute anaemia (aplastic crisis), but may also be associated with other serious complications. We retrospectively analysed clinical data from paediatric SCD patients with B19V infections between 2023 and 2025, including symptoms, laboratory parameters ...
Matthias Bleeke +42 more
wiley +1 more source
Carrying a crisis: The risk of a painful sickle cell crisis during pregnancy
Commentary on: Auger et al. Sickle cell anaemia with and without crises: An observational study of pregnancy outcomes. Br J Haematol 2026 (Online ahead of print). doi: 10.1111/bjh.70837.
Bart J. Biemond
wiley +1 more source
An investigation of the protective effect of alpha+-thalassaemia against severe Plasmodium falciparum amongst children in Kumasi, Ghana [PDF]
Background: The alpha+-thalassaemias are the most common monogenic disorders of humans, characterised by microcytic and hypochromic anaemia. heir high frequency reflects selective advantage against death from Plasmodium falciparum malaria.
Opoku-Okrah, C.
core +1 more source

